Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Cardiovascular Systems, Inc. (NASDAQ:CSII - Get Rating) saw a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling 1,310,000 shares, a decrease of 9.7% from the July 31st total of 1,450,000 shares. Based on an average trading volume of 296,800 shares, the days-to-cover ratio is presently 4.4 days. Currently, 3.9% of the shares of the company are sold short. Cardiovascular Systems Price Performance
Shares of NASDAQ CSII traded up $0.20 during trading hours on Wednesday, reaching $13.71. The stock had a trading volume of 396 shares, compared to its average volume of 239,195. The business's fifty day moving average is $15.34 and its two-hundred day moving average is $17.53. The company has a debt-to-equity ratio of 0.08, a quick ratio of 5.19 and a current ratio of 6.05. Cardiovascular Systems has a twelve month low of $13.37 and a twelve month high of $37.58. Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. SG Americas Securities LLC raised its stake in Cardiovascular Systems by 1,004.9% during the fourth quarter. SG Americas Securities LLC now owns 81,766 shares of the medical device company's stock worth $1,536,000 after acquiring an additional 74,366 shares in the last quarter. Victory Capital Management Inc. raised its stake in Cardiovascular Systems by 5.9% during the fourth quarter. Victory Capital Management Inc. now owns 60,406 shares of the medical device company's stock worth $1,134,000 after acquiring an additional 3,375 shares in the last quarter. First Trust Advisors LP raised its stake in Cardiovascular Systems by 27.0% during the fourth quarter. First Trust Advisors LP now owns 15,302 shares of the medical device company's stock worth $287,000 after acquiring an additional 3,250 shares in the last quarter. BNP Paribas Arbitrage SA raised its stake in Cardiovascular Systems by 344.6% during the fourth quarter. BNP Paribas Arbitrage SA now owns 171,228 shares of the medical device company's stock worth $3,216,000 after acquiring an additional 132,716 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC acquired a new position in Cardiovascular Systems during the fourth quarter worth $359,000. 91.72% of the stock is currently owned by institutional investors and hedge funds. About Cardiovascular Systems (Get Rating)
Cardiovascular Systems, Inc, a medical device company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.See AlsoGet a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)Will The Institutions Buy The Dip In Ambarella Stock? PVH Corporation Is On Track For Capital ReturnsCan Pinterest Rally On Support From Big Investor With Conviction?Chargepoint Rallies, Despite Weaker EarningsIs Cadence Close To A Cup-With-High-Handle Breakout?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cardiovascular Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardiovascular Systems wasn't on the list.
While Cardiovascular Systems currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:
Tom remains optimistic about investors’ prospects going forward, even as the market reacts to the words of Fed Chair Jerome Powell about “pain ahead.”
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.